FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2886804789> ?p ?o ?g. }

• W2886804789 endingPage "4573" @default.
• W2886804789 startingPage "4563" @default.
• W2886804789 abstract "This paper investigated whether positron emission tomography (PET) imaging with [18F]fludarabine ([18F]FDB) can help to differentiate central nervous system lymphoma (CNSL) from glioblastoma (GBM), which is a crucial issue in the diagnosis and management of patients with these aggressive brain tumors. Multimodal analyses with [18F]fluorodeoxyglucose ([18F]FDG), magnetic resonance imaging (MRI) and histology have also been considered to address the specificity of [18F]FDB for CNSL. Methods: Nude rats were implanted with human MC116 lymphoma-cells (n = 9) or U87 glioma-cells (n = 4). Tumor growth was monitored by MRI, with T2-weighted sequence for anatomical features and T1-weighted with gadolinium (Gd) enhancement for blood brain barrier (BBB) permeability assessment. For PET investigation, [18F]FDB or [18F]FDG (~11 MBq) were injected via tail vein and dynamic PET images were acquired up to 90 min after radiotracer injection. Paired scans of the same rat with the two [18F]-labelled radiotracers were investigated. Initial volumes of interest were manually delineated on T2w images and set on co-registered PET images and tumor-to-background ratio (TBR) was calculated to semi-quantitatively assess the tracer accumulation in the tumor. A tile-based method for image analysis was developed in order to make comparative analysis between radiotracer uptake and values extracted from immunohistochemistry staining. Results: In the lymphoma model, PET time-activity curves (TACs) revealed a differential response of [18F]FDB between tumoral and healthy tissues with average TBR varying from 2.45 to 3.16 between 5 to 90 min post-injection. In contrast, [18F]FDG demonstrated similar uptake profiles for tumoral and normal regions with TBR varying from 0.84 to 1.06 between these two time points. In the glioblastoma (GBM) model, the average TBRs were from 2.14 to 1.01 for [18F]FDB and from 0.95 to 1.65 for [18F]FDG. Therefore, inter-model comparisons showed significantly divergent responses (p < 0.01) of [18F]FDB between lymphoma and GBM, while [18F]FDG demonstrated overlap (p = 0.04) between the groups. Tumor characterization with histology (based mainly on Hoechst and CD79), as well as with MRI was overall in better agreement with [18F]FDB-PET than [18F]FDG with regard to tumor selectivity. Conclusions: [18F]FDB-PET demonstrated considerably greater specificity for CNSL when compared to [18F]FDG. It also permitted a more precise definition of target volume compared to contrast-enhanced MRI. Therefore, the potential of [18F]FDB-PET to distinguish CNSL from GBM is quite evident and will be further investigated in humans." @default.
• W2886804789 created "2018-08-22" @default.
• W2886804789 creator A5005278396 @default.
• W2886804789 creator A5016314262 @default.
• W2886804789 creator A5027348968 @default.
• W2886804789 creator A5038234436 @default.
• W2886804789 creator A5065672564 @default.
• W2886804789 creator A5070032516 @default.
• W2886804789 creator A5075653366 @default.
• W2886804789 creator A5075946256 @default.
• W2886804789 creator A5079665530 @default.
• W2886804789 date "2018-01-01" @default.
• W2886804789 modified "2023-10-15" @default.
• W2886804789 title "[¹⁸F]Fludarabine-PET as a promising tool for differentiating CNS lymphoma and glioblastoma: Comparative analysis with [¹⁸F]FDG in human xenograft models" @default.
• W2886804789 cites W1218170828 @default.
• W2886804789 cites W1526669333 @default.
• W2886804789 cites W1568033114 @default.
• W2886804789 cites W1593555249 @default.
• W2886804789 cites W1966222473 @default.
• W2886804789 cites W1978100438 @default.
• W2886804789 cites W1991468486 @default.
• W2886804789 cites W1997474747 @default.
• W2886804789 cites W2018189509 @default.
• W2886804789 cites W2024873263 @default.
• W2886804789 cites W2027198976 @default.
• W2886804789 cites W2027703570 @default.
• W2886804789 cites W2027736847 @default.
• W2886804789 cites W2037178901 @default.
• W2886804789 cites W2043304820 @default.
• W2886804789 cites W2056132925 @default.
• W2886804789 cites W2068823347 @default.
• W2886804789 cites W2069490843 @default.
• W2886804789 cites W2089419946 @default.
• W2886804789 cites W2091077642 @default.
• W2886804789 cites W2092328603 @default.
• W2886804789 cites W2095272243 @default.
• W2886804789 cites W2096191438 @default.
• W2886804789 cites W2098095232 @default.
• W2886804789 cites W2100485814 @default.
• W2886804789 cites W2103808961 @default.
• W2886804789 cites W2113122028 @default.
• W2886804789 cites W2127507395 @default.
• W2886804789 cites W2127565050 @default.
• W2886804789 cites W2130961502 @default.
• W2886804789 cites W2134346052 @default.
• W2886804789 cites W2144574942 @default.
• W2886804789 cites W2151806077 @default.
• W2886804789 cites W2160300569 @default.
• W2886804789 cites W2164728045 @default.
• W2886804789 cites W2171632483 @default.
• W2886804789 cites W2176471825 @default.
• W2886804789 cites W2184036762 @default.
• W2886804789 cites W2212334442 @default.
• W2886804789 cites W2315264397 @default.
• W2886804789 cites W2336445750 @default.
• W2886804789 cites W2433681782 @default.
• W2886804789 cites W2473036915 @default.
• W2886804789 cites W2558459252 @default.
• W2886804789 cites W2571239276 @default.
• W2886804789 cites W2592239897 @default.
• W2886804789 cites W2610149334 @default.
• W2886804789 cites W2611383424 @default.
• W2886804789 cites W2753506647 @default.
• W2886804789 cites W2762142844 @default.
• W2886804789 cites W2786933539 @default.
• W2886804789 cites W826060588 @default.
• W2886804789 doi "https://doi.org/10.7150/thno.26754" @default.
• W2886804789 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6134939" @default.
• W2886804789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30214639" @default.
• W2886804789 hasPublicationYear "2018" @default.
• W2886804789 type Work @default.
• W2886804789 sameAs 2886804789 @default.
• W2886804789 citedByCount "12" @default.
• W2886804789 countsByYear W28868047892019 @default.
• W2886804789 countsByYear W28868047892020 @default.
• W2886804789 countsByYear W28868047892021 @default.
• W2886804789 countsByYear W28868047892022 @default.
• W2886804789 countsByYear W28868047892023 @default.
• W2886804789 crossrefType "journal-article" @default.
• W2886804789 hasAuthorship W2886804789A5005278396 @default.
• W2886804789 hasAuthorship W2886804789A5016314262 @default.
• W2886804789 hasAuthorship W2886804789A5027348968 @default.
• W2886804789 hasAuthorship W2886804789A5038234436 @default.
• W2886804789 hasAuthorship W2886804789A5065672564 @default.
• W2886804789 hasAuthorship W2886804789A5070032516 @default.
• W2886804789 hasAuthorship W2886804789A5075653366 @default.
• W2886804789 hasAuthorship W2886804789A5075946256 @default.
• W2886804789 hasAuthorship W2886804789A5079665530 @default.
• W2886804789 hasBestOaLocation W28868047891 @default.
• W2886804789 hasConcept C126838900 @default.
• W2886804789 hasConcept C142724271 @default.
• W2886804789 hasConcept C143409427 @default.
• W2886804789 hasConcept C178790620 @default.
• W2886804789 hasConcept C185592680 @default.
• W2886804789 hasConcept C204232928 @default.
• W2886804789 hasConcept C2775842073 @default.
• W2886804789 hasConcept C2775934546 @default.
• W2886804789 hasConcept C2776194525 @default.

• next